These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34739880)

  • 1. Melatonin and risk of mortality in subjects with aneurysmal subarachnoid hemorrhage.
    Lin SH; Galet C; Zanaty M; Bayman E; Rogers WK; Hasan D; Allan LD
    Clin Neurol Neurosurg; 2021 Nov; 210():106990. PubMed ID: 34739880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Clinical Impact of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: Analysis from the China National Stroke Registry.
    Duan W; Pan Y; Wang C; Wang Y; Zhao X; Wang Y; Liu L;
    Neuroepidemiology; 2018; 50(3-4):128-136. PubMed ID: 29529609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Rowland MJ; Garry P; Westbrook J; Corkill R; Antoniades CA; Pattinson KTS
    J Neurosurg; 2017 Oct; 127(4):754-760. PubMed ID: 27935361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus.
    Yousef K; Crago E; Kuo CW; Horowitz M; Hravnak M
    Neurocrit Care; 2010 Dec; 13(3):366-72. PubMed ID: 20645025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-ictal antiplatelet therapy use in aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Ogulnick J; Feldstein E; Damodara N; Bravo M; Alshammari H; Dominguez J; Cooper J; Huang KT; Marikunte S; Ali S; Patel V; Khandelwal P; Mayer SA; Amuluru K; Gandhi CD
    Clin Neurol Neurosurg; 2021 Dec; 211():107022. PubMed ID: 34781219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: Functional outcome and long-term mortality.
    Olsen MH; Orre M; Leisner ACW; Rasmussen R; Bache S; Welling KL; Eskesen V; Møller K
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1191-1199. PubMed ID: 31173342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low total cholesterol and high density lipoprotein are independent predictors of poor outcomes following aneurysmal subarachnoid hemorrhage: A preliminary report.
    Li B; McIntyre M; Gandhi C; Halabi M; Long A; Van Hoof A; Afridi A; Schmidt M; Cole C; Santarelli J; Al-Mufti F; Bowers C
    Clin Neurol Neurosurg; 2020 Oct; 197():106062. PubMed ID: 32688095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
    Foreman PM; Chua M; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Walters BC; Tubbs RS; Shoja MM; Griessenauer CJ
    J Neurosurg; 2016 Dec; 125(6):1383-1389. PubMed ID: 26871202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of serum complement component 1q levels in the prognostic analysis of aneurysmal subarachnoid hemorrhage: a prospective cohort study.
    Wang L; Zhou H; Zheng W; Wang H; Wang Z; Dong X; Du Q
    Front Neurol; 2024; 15():1341731. PubMed ID: 38356892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study.
    Chalouhi N; Daou B; Okabe T; Starke RM; Dalyai R; Bovenzi CD; Anderson EC; Barros G; Reese A; Jabbour P; Tjoumakaris S; Rosenwasser R; Kraft WK; Rincon F
    J Neurosurg; 2016 Sep; 125(3):730-6. PubMed ID: 26799296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Initial Vasopressors Used for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.
    Roy B; McCullough LD; Dhar R; Grady J; Wang YB; Brown RJ
    Cerebrovasc Dis; 2017; 43(5-6):266-271. PubMed ID: 28319954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
    Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
    Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2018 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Propensity Score Analysis of the Impact of Dexamethasone Use on Delayed Cerebral Ischemia and Poor Functional Outcomes After Subarachnoid Hemorrhage.
    Mohney N; Williamson CA; Rothman E; Ball R; Sheehan KM; Pandey AS; Fletcher JJ; Jacobs TL; Thompson BG; Rajajee V
    World Neurosurg; 2018 Jan; 109():e655-e661. PubMed ID: 29061461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sex differences on outcomes after aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis.
    Han Y; Zhang B; Qi X; Yuan G; Li X; Hao G; Liang G
    BMC Neurol; 2024 May; 24(1):153. PubMed ID: 38704548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of a Grading System for Predicting Discharge Mortality and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Maragkos GA; Enriquez-Marulanda A; Salem MM; Ascanio LC; Chida K; Gupta R; Alturki AY; Kicielinski KP; Ogilvy CS; Moore JM; Thomas AJ
    World Neurosurg; 2019 Jan; 121():e500-e510. PubMed ID: 30268551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.
    Ma C; Zhou W; Yan Z; Qu M; Bu X
    J Neurol Sci; 2015 Dec; 359(1-2):67-71. PubMed ID: 26671088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Barrow Neurological Institute Grading Scale as a Predictor for Delayed Cerebral Ischemia and Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From a Nationwide Patient Registry (Swiss SOS).
    Neidert MC; Maldaner N; Stienen MN; Roethlisberger M; Zumofen DW; D'Alonzo D; Marbacher S; Maduri R; Hostettler IC; Schatlo B; Schneider MM; Seule MA; Schöni D; Goldberg J; Fung C; Arrighi M; Valsecchi D; Bijlenga P; Schaller K; Bozinov O; Regli L; Burkhardt JK;
    Neurosurgery; 2018 Dec; 83(6):1286-1293. PubMed ID: 29351673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.